This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brook, I.
Right arrow Articles by Foote, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brook, I.
Right arrow Articles by Foote, P. A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, November 2005, p. 4787-4788, Vol. 49, No. 11
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.11.4787-4788.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Efficacy of Penicillin versus Cefdinir in Eradication of Group A Streptococci and Tonsillar Flora

Itzhak Brook1* and Perry A. Foote2

Department of Pediatrics, Georgetown University School of Medicine, Washington, D.C.,1 Department of Otorhinolaryngology, University of Florida, Alachua General Hospital, Gainesville, Florida2

Received 4 May 2005/ Returned for modification 1 July 2005/ Accepted 21 August 2005

Core tonsillar cultures were obtained from 40 children with recurrent tonsillitis treated with either penicillin or cefdinir. Group A beta-hemolytic streptococci were isolated from 11 penicillin- and 3 cefdinir-treated (P < 0.001) patients. ß-Lactamase producers were recovered from 17 penicillin- and 3 cefdinir-treated (P < 0.01) patients. Inhibiting alpha-hemolytic streptococci were isolated less often from penicillin-treated patients than from cefdinir-treated patients.


* Corresponding author. Mailing address: 4431 Albemarle St. NW, Washington, DC 20016. Fax: (202) 244-6809. Phone: (301) 295-2698. E-mail: ib6{at}georgetown.edu.


Antimicrobial Agents and Chemotherapy, November 2005, p. 4787-4788, Vol. 49, No. 11
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.11.4787-4788.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Casey, J. R., Kahn, R., Gmoser, D., Atlas, E., Urbani, K., Luber, S., Pellman, H., Pichichero, M. E. (2008). Frequency of Symptomatic Relapses of Group A {beta}-Hemolytic Streptococcal Tonsillopharyngitis in Children From 4 Pediatric Practices Following Penicillin, Amoxicillin, and Cephalosporin Antibiotic Treatment. CLIN PEDIATR 47: 549-554 [Abstract]  
  • Brook, I. (2007). Penicillin Failure in the Treatment of Acute and Relapsing Tonsillopharyngitis Is Associated With Copathogens and Alteration of Microbial Balance: A Role for Cephalosporins. CLIN PEDIATR 46: 17S-24S [Abstract]  
  • Casey, J. R. (2007). Selecting the Optimal Antibiotic in the Treatment of Group A {beta}-Hemolytic Streptococci Pharyngitis. CLIN PEDIATR 46: 25S-35S [Abstract]  
  • Brook, I., Gober, A. E. (2006). Recovery of interfering and {beta}-lactamase-producing bacteria from group A {beta}-haemolytic streptococci carriers and non-carriers.. J Med Microbiol 55: 1741-1744 [Abstract] [Full Text]